Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Venus Concept Inc. (VERO : NSDQ)

• Company Description    Venus Concept Inc. designs and develops medical aesthetic equipment. The company's product portfolio consists of aesthetic device platforms, including Venus Versa(TM), Venus Legacy(TM), Venus Velocity(TM), Venus Fiore(TM), Venus Viva(TM), Venus Freeze Plus(TM) and Venus Bliss(TM). It also provides NeoGraft(R), an automated hair restoration system; ARTAS(R) and ARTAS Ix(TM) Robotic Hair Restoration Systems. Venus Concept Inc., formerly known as Restoration Robotics Inc., is based in TORONTO. Number of Employees: 292

• Price / Volume Information    Yesterday's Closing Price: $2.51 Daily Weekly Monthly 20 Day Moving Average: 1,095,729 shares Shares Outstanding: 1.42 (millions) Market Capitalization: $3.58 (millions) Beta: 0.07 52 Week High: $11.87 52 Week Low: $2.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 3.29% -1.03% 12 Week -2.71% -17.61% Year To Date -39.40% -42.92%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 235 YORKLAND BLVD. SUITE 900 - TORONTO,A6 M2J 4Y8 CAN ph: 877-848-8430 fax: - venusconceptir@westwicke.com http://www.venus.ai

• General Corporate Information    Officers Rajiv De Silva - Chief Executive Officer and Director Scott Barry - Chairman and Director Domenic Della Penna - Chief Financial Officer Louise Lacchin - Director Fritz LaPorte - Director Peer Information Venus Concept Inc. (ABMD) Venus Concept Inc. (DMDS) Venus Concept Inc. (CPWY.) Venus Concept Inc. (EQUR) Venus Concept Inc. (ECIA) Venus Concept Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 92332W303 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/12/25 Share - Related Items Shares Outstanding: 1.42 Most Recent Split Date: 3.00 (0.09:1) Beta: 0.07 Market Capitalization: $3.58 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.31 Price/Cash Flow: - Price / Sales: 0.06 EPS Growth vs. Year Ago Period: 5.64% vs. Previous Quarter: -55.30% Sales Growth vs. Year Ago Period: -21.95% vs. Previous Quarter: -13.46% ROE 06/30/25 - - 03/31/25 - -752.29 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -54.52 12/31/24 - -47.29 Current Ratio 06/30/25 - - 03/31/25 - 1.28 12/31/24 - 1.60 Quick Ratio 06/30/25 - - 03/31/25 - 0.79 12/31/24 - 1.02 Operating Margin 06/30/25 - - 03/31/25 - -63.39 12/31/24 - -55.67 Net Margin 06/30/25 - - 03/31/25 - -81.26 12/31/24 - -72.49 Pre-Tax Margin 06/30/25 - - 03/31/25 - -81.74 12/31/24 - -73.39 Book Value 06/30/25 - - 03/31/25 - 1.92 12/31/24 - 4.30 Inventory Turnover 06/30/25 - - 03/31/25 - 1.06 12/31/24 - 1.06 Debt-to-Equity 06/30/25 - - 03/31/25 - 7.91 12/31/24 - 11.08 Debt-to-Capital 06/30/25 - - 03/31/25 - 88.77 12/31/24 - 91.72

Powered by Zacks Investment Research ©